Ohio State Navbar

Sign In

1st Annual Stem Cell Symposium

The Nationwide Children's Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Nationwide Children's Hospital designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Cell-based therapies: A new era in patient care

Monday, October 14, 2013, at Nationwide Children's Hospital, Columbus Ohio

We welcome you to join us at Nationwide Children's Hospital in Columbus, Ohio to discuss advancements in cellular therapies on October 14, 2013. The Division of Hematology/Oncology/BMT at Nationwide Children's Hospital, the NCI-designated James Comprehensive Cancer Center, the Ohio State University Center of Regenerative Medicine and Cell-Based Therapies, and the International Society of Cellular Therapy have partnered together to bring you this educational experience.

We look forward to presentations given by national speakers from Seattle, Houston, Minneapolis, and Atlanta, who will discuss their research involving chimeric antigen receptor redirected T-cell therapy (CAR T-cells), mesenchymal stromal cells (MSCs), umbilical cord blood cell expansion platforms, and other related topics. These world-class speakers will share their research findings and lead collaborative discussions about advancements occurring in the field of cell-based therapies that are impacting the lives of oncology and stem cell transplant patients.


8:00am – 8:30am Registration and Continental Breakfast
8:30am – 8:40am Welcome
John Barnard, MD
The Research Institute at
Nationwide Children's Hospital, Columbus, OH
8:40am – 8:45am Introduction: Hematopoietic and immune cell therapies
Jeffery Auletta, MD
Nationwide Children's Hospital, Columbus, OH

Steven Devine, MD
The James Comprehensive Cancer Center, Columbus, OH
8:45am – 9:30am Chimeric antigen receptor (CAR) redirected T-cell therapy
Michael Jensen, MD
Seattle Children's Research Institute, Seattle, WA
9:30am – 10:15am Viral-specific cytotoxic lymphocyte (CTL) therapy
Ann Leen, PhD
Baylor College of Medicine, Houston, TX
10:15am – 11:00am Umbilical cord blood cell expansion platforms
Elizabeth J. Shpall, MD
MD Anderson Cancer Center, Houston, TX
11:00am – 11:30am Speaker panel: Q&A
11:30am – 12:55pm ISCT lunchworkshop: "Process Development for Cell Therapy Clinical Trials"
Julie Allickson, PhD
Wake Forest Institute for Regenerative Medicine, Winston Salem, NC

Allan Dietz, PhD
Mayo Clinic Center for Regenerative Medicine, Rochester, MN
12:55pm – 1:00pm Introduction: Non-hematopoietic stem and stromal cell therapies
Thomas Gross, MD, PhD
Nationwide Children's Hospital, Columbus, OH

Lynn O'Donnell, PhD
The James Comprehensive Cancer Center, Columbus, OH
1:00pm – 1:45pm Mesenchymal stromal cell-based immunomodulation
Jeffery Auletta, MD
Nationwide Children's Hospital, Columbus, OH
1:45pm – 2:30pm MSC expansion platforms and potency assays
Jacques Galipeau, MD
Emory University, Atlanta, GA
2:30pm – 2:45pm Break
3:45pm – 3:30pm Inducible pluripotent stem cells
Jakub Tolar, MD, PhD
University of Minnesota, Minneapolis, MN
3:30pm – 4:15pm Bringing cell-based therapies into the clinic: an industry perspective on clinical design and academic collaboration
Robert Deans, PhD
Athersys, Cleveland, OH
4:15pm – 4:45pm Speaker panel: Q&A
4:45pm Wrap-up and Adjourn


For questions or for further information, please contact Mark.Grillo@nationwidechildrens.org or call our Professional Conferences Phone Line at (614)355-0676.